MENU
MGX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Metagenomi Therapeutics (MGX) Earnings Date & Reports

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox... Show more

A.I. Advisor
published Earnings

MGX is expected to report earnings to rise 47.27% to -81 cents per share on April 01

Metagenomi Therapeutics MGX Stock Earnings Reports
Q4'25
Est.
$-0.81
Q3'25
Beat
by $0.25
Q2'25
Beat
by $0.18
Q1'25
Beat
by $0.07
Q4'24
Beat
by $0.40
The last earnings report on November 11 showed earnings per share of -55 cents, beating the estimate of -80 cents. With 239.58K shares outstanding, the current market capitalization sits at 64.58M.
View a ticker or compare two or three
MGX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MGX showed earnings on November 11, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
5959 Horton Street
Phone
+1 510 871-4880
Employees
236
Web
https://www.metagenomi.co